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Introduction {#sec1}
============

Obesity is a global disease associated with metabolic disorders such as diabetes, hypertension, and cardiovascular disease ([@bib14]). Studies of the complex process by which adipocytes differentiate from preadipocyte precursors (i.e., adipogenesis) are important for understanding the underlying mechanisms of this disease ([@bib8]). The 3T3-L1 preadipocyte cell line is an *in vitro* model widely used to study the molecular mechanisms of adipocyte differentiation ([@bib19]). When proliferating 3T3-L1 preadipocytes become confluent in culture dishes, they enter G~1~ growth-arrest phase ([@bib26]). Upon treatment with hormonal cocktail (a mixture of 3-isobutyl-1-methylxanthine, dexamethasone, and insulin, hereafter called MDI) and fetal bovine serum (FBS), growth-arrested preadipocytes reenter the cell cycle and initiate differentiation via serial expression of adipogenic genes such as those encoding CCAAT/enhancer binding protein (C/EBP) β, C/EBPα, and peroxisome proliferator-activated receptor γ (PPARγ) ([@bib18], [@bib25]). This resumed cell cycle is called mitotic clonal expansion, and the process sustains during the first 2--3 days of differentiation and is essential for 3T3-L1 differentiation because an inhibition of this step completely blocks adipogenesis ([@bib26]).

In our previous studies to identify important differentiation factors secreted by clonally expanding cells, we observed that the differentiation program was accelerated in adipocytes treated with conditioned medium (CM) relative to those treated with MDI ([@bib2]). Moreover, the CM-treated cells expressed adipocyte-specific genes before undergoing clonal expansion ([@bib2]). Thus, the aim of the present study was to reveal the factors in CM responsible for promoting adipogenesis. To this end, we began by screening gene expression changes in cells treated with CM. We subsequently identified the serine protease Serpina3c as a protein regulating 3T3-L1 preadipocyte differentiation. Serpina3c is a member of the Serpin superfamily, and some Serpin family proteins have been implicated in adipocyte differentiation and obesity in the proteomic study ([@bib27]); however, their precise physiological roles are unknown. Serpina3c is classified in the serpin A clade, which comprises 11 genes (*SERPINA1* and *SERPINA3* to -*12*) and 2 pseudogenes (*SERPINA2* and *SERPINA13P*) in humans and 9 genes (*Serpina3a, -b, -c,* and -*f* to -*n*) in mice ([@bib9]). Serpina3 is a known inhibitor of chymotrypsin and cathepsin G ([@bib16]) and is reported to be expressed in the blood, liver, kidney, and lung ([@bib9]). We reveal here that Serpina3c is highly expressed in adipose tissue of mice and has an important role in adipocyte differentiation. This effect was closely associated with ERK and AKT activation via insulin-like growth factor 1 (IGF-1) signaling, which involves a complex formed by the IGF-1 receptor (IGF-1R) and the integrin α5-β3 heterodimer ([@bib23]). We further demonstrate that Serpina3c inhibits a serine protease that degrades integrin α5. Thus, Serpina3c is a critical factor involved in the early signaling pathway of adipogenesis, and inhibition of Serpina3c may offer beneficial effects in the treatment of obesity.

Results {#sec2}
=======

Serpina3c Is Expressed and Secreted by Differentiating Adipocytes {#sec2.1}
-----------------------------------------------------------------

3T3-L1 preadipocytes were cultured to confluence in Dulbecco\'s modified Eagle\'s medium supplemented with 10% calf serum. Two days later, the cells were treated with MDI and FBS to induce cell-cycle reentry and preadipocyte differentiation. On differentiation day 2, the medium (i.e., CM) was collected and used to treat 3T3-L1 preadipocytes. Cells were then harvested 0, 4, or 24 h after treatment with CM (or MDI as a control) for RNA sequencing ([Figure 1](#fig1){ref-type="fig"}A). As previously observed ([@bib2]), the terminal differentiation of CM-treated 3T3-L1 adipocytes was accelerated as evidenced by Oil Red O staining ([Figure 1](#fig1){ref-type="fig"}B). To identify genes associated with this acceleration, we focused on genes (1) upregulated \>2-fold by MDI and FBS after 24 h of differentiation, (2) induced immediately (at 4 h of differentiation) by CM, and (3) with a CM/MDI ratio \>2-fold at 4 h of differentiation ([Figure 1](#fig1){ref-type="fig"}C). We thought that these criteria would meet a critical condition to find factors that are up-regulated by CM, that is, by the factors secreted by differentiating adipocytes. This enables us to identify \~20 candidate genes ([Figure 1](#fig1){ref-type="fig"}D; the total gene expression dataset is available in [Data S1](#mmc2){ref-type="supplementary-material"}). Of these, *Serpina3c* and *Serpina3n* have attracted immediate attention, because these are predicted as secreting molecules whose roles are not clarified in adipogenesis yet.Figure 1Gene Expression Profile in Differentiating 3T3-L1 Cells Treated with CM(A) A schematic model of CM preparation using a 3T3-L1 preadipocyte differentiation system. Confluent growth-arrested 3T3-L1 preadipocytes were induced to differentiate with MDI and FBS. After 2 days, cell-exposed medium was collected to treat other preadipocytes. Differentiating cells were harvested after 0, 4, and 24 h for RNA sequencing. MDI + FBS-treated cells were used as a control group.(B) CM accelerated 3T3-L1 adipocyte differentiation as shown by Oil Red O staining at day 5 of induction.(C) Strategy for the identification of CM-containing factors via RNA sequencing data.(D) Heatmap showing relative expression of 20 genes identified from RNA sequencing data. Red, high expression; blue, low expression. Fold changes of the total genes are presented in [Data S1](#mmc2){ref-type="supplementary-material"}. These RNA sequencing data using MDI and CM are publicly available from Gene Expression Omnibus (GEO: [GSE144130](ncbi-geo:GSE144130){#intref0015}).

We further examined the expression of *Serpina3c* and *Serpina3n* during the course of 3T3-L1 differentiation. In cells treated with MDI, *Serpina3c* expression gradually increased, peaking at 24--48 h, whereas the expression of *Serpina3n* did not change markedly ([Figures 2](#fig2){ref-type="fig"}A and 2B). By contrast, the expression of *Serpina3c* rapidly reached the highest level soon after CM treatment and maintained this level during the whole differentiation process ([Figures 2](#fig2){ref-type="fig"}A and 2B). During the late stage of adipogenesis, the expression levels of adipokines such as leptin and adiponectin were not affected by *Serpina3c* ([Figure 2](#fig2){ref-type="fig"}C). *Serpina3c* mRNA expression was high in white adipose tissues and liver but much lower in other mouse tissues ([Figure 2](#fig2){ref-type="fig"}D). These data are in accordance with a role for Serpina3c in adipocyte differentiation and the rapid progression of adipogenesis induced by CM.Figure 2General Characterization of Serpina3c in Adipocytes(A--C) *Serpina3c* expression patterns induced by MDI or CM treatment in 3T3-L1 adipocytes. Cell lysate were prepared at various times, (A) 0∼6 h or (B) 0∼120 h after treatment for RT-PCR analysis of *Serpina3c*, *Serpina3n*, and *Gapdh*. (C) Also, the expression of adipokines, *Leptin* and *AdipoQ*, was compared with those of *Serpina3c* and *Serpina3n*.(D) Tissue distribution of *Serpina3c* by RT-PCR in C57BL/6 male mice.(E) Amino acid sequence of Serpina3c was analyzed by SignalP-4.1 prediction ([www.cbs.dtu.dk/services/SignalP-4.1/](http://www.cbs.dtu.dk/services/SignalP-4.1/){#intref0020}) showing the N-terminal signal peptide for secretory proteins.(F) Overexpression vector was generated by inserting mouse *Serpina3c* (or *Serpina3n*) encoding a C-terminal FLAG tag into pcDNA3.0. HEK293T cells were transfected with this construct, and 2 days later, the medium was collected, precipitated by cold acetone, and subjected to western blot analysis to detect the FLAG-tagged protein secreted from cells. pcDNA3.0 was used as a negative control.(G) Serpina3c expression and secretion patterns induced by MDI in 3T3 L1 adipocytes. RT-PCR was performed to detect expression of *Serpina3c* mRNA after treatment. Western blot analysis was performed to investigate expression and secretion of Serpina3c protein in precipitated media or cell lysate after treatment.

Serpina3c (also known as alpha 1 proteinase inhibitor antitrypsin \[[@bib9], [@bib16]\]) is predicted to be a secretory protein with a signal peptide on its N terminus ([Figure 2](#fig2){ref-type="fig"}E). To confirm that it is a secretory protein, we generated Serpina3c and Serpina3n overexpression vectors with FLAG tags and transfected them into HEK293T cells. Serpina3c and -3n proteins were detected in the medium from transfected cells ([Figure 2](#fig2){ref-type="fig"}F), indicating that they are indeed secreted from cells. In addition, the secretion of Serpina3c protein was paralleled with intracellular expression of *Serpina3c* ([Figure 2](#fig2){ref-type="fig"}G).

Knockdown of *Serpina3c* Inhibits Mitotic Clonal Expansion and Adipocyte Differentiation {#sec2.2}
----------------------------------------------------------------------------------------

To clarify the role of Serpina3c or Serpina3n in adipogenesis, we knocked down expression via RNA interference. Although *Serpina3c* and *Serpina3n* are located on the same chromosome and encode proteins with similar amino acid sequences, only knockdown of *Serpina3c* affected 3T3-L1 adipogenesis ([Figures 3](#fig3){ref-type="fig"}A and 3B). Interestingly, the effect of *Serpina3c* knockdown was observed in cells treated with MDI but not with CM, indicating that CM may already contain Serpina3c secreted by differentiating cells. In other words, differentiating 3T3-L1 cells with MDI secrete Serpina3c into the medium (i.e., CM), then CM-treated 3T3-L1 cells no longer require Serpina3c expression.Figure 3Serpina3c Is Required for Mitotic Clonal Expansion during Adipogenesis(A and B) 3T3-L1 cells were transfected with negative control (NC), *Serpina3c*, or *Serpina3n* siRNAs. Differentiation of transfected cells was induced by MDI or CM. Serpina3c depletion abolishes 3T3-L1 differentiation in MDI-treated cells. Oil Red O staining was conducted on day 8 (A) and knockdown of *Serpina3c* was assessed by RT-PCR (B).(C) Cell proliferation determined by cell counting at 0, 16, 24, 36, and 48 h after MDI treatment. Data are represented as mean ± SE. p Values less than 0.05 were considered significant, with ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s t test.(D) Cell-cycle analysis by flow cytometry at the indicated time points.(E) Western blot analysis was performed for differentiation markers of adipocytes in control cells and those with *Serpina3c* knockdown (si-Serpina3c).

During mitotic clonal expansion, cell numbers normally increase 2- to 3-fold ([@bib15], [@bib17]). However, this was not observed in cells with *Serpina3c* knockdown after MDI induction ([Figure 3](#fig3){ref-type="fig"}C). These results were confirmed by fluorescence-activated cell sorting analysis. The G~1~-S~2~ transition was inhibited in cells with *Serpina3c* knockdown, whereas more control cells reentered the cell cycle after MDI treatment ([Figure 3](#fig3){ref-type="fig"}D). Consistent with a role for Serpina3c in adipogenesis, knockdown of *Serpina3c* resulted in reduced expression of PPARγ and C/EBPα ([Figure 3](#fig3){ref-type="fig"}E). This result suggests that Serpina3c is associated with mitotic clonal expansion in adipogenesis.

Serpina3c Is Involved in Adipogenesis via the Integrin-Mediated IGF-1 Pathway {#sec2.3}
-----------------------------------------------------------------------------

As human SERPINA3 is reported as an inhibitor of cathepsin G ([@bib9], [@bib16]), a type of serine protease known to modulate integrin clustering in neutrophils and induce integrin cleavage in platelets ([@bib20], [@bib22]), we speculated that integrin regulation may be altered in cells with *Serpina3c* knockdown. Western blotting revealed that integrin α5 but not integrin α6 was decreased by *Serpina3c* knockdown ([Figure 4](#fig4){ref-type="fig"}A). Integrin α5 and β3 heterodimerize and interact with IGF-1R ([@bib21]), and in the presence of IGF-1, Tyr759 of integrin β3 is phosphorylated and binds Src ([@bib3], [@bib5]). As shown in [Figure 4](#fig4){ref-type="fig"}A, integrin β3 phosphorylation was diminished in cells with *Serpina3c* knockdown, suggesting that integrin-IGF-1R signaling is altered. Accordingly, phosphorylation of the downstream signaling enzyme ERK, which is required for C/EBPβ phosphorylation and mitotic clonal expansion in adipogenesis ([@bib13], [@bib25]), was decreased by *Serpina3c* knockdown. Notably, the expression of integrin α5 mRNA was increased by *Serpina3c* knockdown ([Figure 4](#fig4){ref-type="fig"}B), indicating that the effect of Serpina3c is not at the level of transcription but rather at the level of protein translation or degradation. Nevertheless, knockdown of integrin α5 mRNA inhibited adipocyte differentiation with MDI. With CM treatment, adipogenesis of si-Serpina3c cells was slightly rescued owing to the intracellular Serpina3c protein in CM. In contrast, knockdown of integrin α5, a downstream molecule of Serpina3c, showed no change between MDI and CM treatment ([Figure 4](#fig4){ref-type="fig"}C). Besides transducing signals from the extracellular matrix to the cell, integrin also serves to attach the cell to the extracellular matrix ([@bib6]). Our experiment indicates that knockdown of integrin α5, without altering cellular structure, blocks adipogenesis by inhibiting ERK signaling ([Figure 4](#fig4){ref-type="fig"}D). Confocal microscopy also has shown that the cellular structure of integrin α5 knockdown cells was not changed during differentiation ([Figure S1](#mmc1){ref-type="supplementary-material"}).Figure 4Knockdown of *Serpina3c* Results in Integrin α5-mediated ERK Inactivation(A) 3T3-L1 cells were transfected with either negative control siRNA (NC) or si-Serpina3c and then differentiated using MDI. Integrin α5, β3, and α6 and phosphorylated integrin β3 and ERK were detected by western blotting at the indicated time points.(B) RT-PCR was performed to assess the expression of integrin α5, β3, and α6. 3T3-L1 cells were transfected with NC or *Serpina3c* siRNA, and then differentiation was induced by MDI.(C) Cells treated with NC, si-Serpina3c (si-3C), or si-Integrin α5 (si-α5) were stained with Oil Red O on day 6, and depletion of Serpina3c or integrin α5 was assessed by RT-PCR.(D) Microscopy images of cells 2 days after transfections with NC and si-α5. Cell structure was not changed. Western blot analysis was performed for ERK and phosphorylated ERK. Scale bar, 50 μm.(E) Cathepsin G activity was measured in 3T3-L1 cells transfected with NC or si-Serpina3c on day 0 or day 1 after differentiation. Data are represented as mean ± SD. p Values less than 0.05 were considered significant, with ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s t test.(F) Gene expression changes of PPARγ and C/EBPα during differentiation after treatment with cathepsin G inhibitor. Data are represented as mean ± SD. p Values less than 0.05 were considered significant, with ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s t test.

How does Serpina3c contribute to the maintenance of integrin α5 protein? To this end, we measured cathepsin G activity. During adipogenesis, cathepsin G activity was significantly increased during adipocyte differentiation in cells with *Serpina3c* knockdown ([Figure 4](#fig4){ref-type="fig"}E). Moreover, administration of a synthetic cathepsin G inhibitor during adipogenesis increased PPARγ and C/EBPα expression, suggesting that the inhibition of cathepsin G promotes adipogenesis ([Figure 4](#fig4){ref-type="fig"}F). Altogether, these data show that Serpina3c leads to the inhibition of cathepsin G, thereby protecting integrin α5 from degradation.

*Serpina3c* Knockdown Attenuates Nuclear Translocation of GSK3β via Prolonged AKT Activation {#sec2.4}
--------------------------------------------------------------------------------------------

We next investigated AKT activation, which is also induced by IGF-1 signaling ([@bib12]). Knockdown of *Serpina3c* prolonged the increase in AKT phosphorylation during differentiation ([Figure 5](#fig5){ref-type="fig"}A). Accordingly, phosphorylation of the downstream target glycogen synthase kinase 3β (GSK3β) was also prolonged ([Figure 5](#fig5){ref-type="fig"}A). Phosphorylated GSK3β does not translocate to the nucleus ([@bib24]). Consistent with this, no phosphorylated GSK3β was detected in the nuclear fraction of 3T3-L1 adipocytes, and a decreased amount of nuclear GSK3β was observed in cells with *Serpina3c* knockdown ([Figure 5](#fig5){ref-type="fig"}B), indicating that nuclear translocation was suppressed. The inhibition of GSK3β nuclear translocation by knockdown of *Serpina3c* was confirmed by immunocytochemistry ([Figure 5](#fig5){ref-type="fig"}C). Thus, Serpina3c promotes GSK3β translocation to the nucleus, which is required for the phosphorylation of Ser184 and Thr179 of C/EBPβ that is necessary for adipogenesis ([@bib24]).Figure 5*Serpina3c* knockdown Induces Prolonged AKT Phosphorylation Resulting in Inhibited GSK3β Translocation3T3-L1 cells were transfected with NC or si-Serpina3c and then differentiated using MDI.(A) Protein levels in transfected cells were measured by western blotting.(B) Nuclear extracts (NE) and whole-cell lysates were prepared 24 h after MDI treatment and phosphorylated (p) GSK3β and GSK3β levels were measured by western blotting. LaminA/C and GAPDH were used as nuclear and cytosol protein marker, respectively.(C) Cells transfected with NC or si-Serpina3c were induced to differentiate with MDI and fixed for immunocytochemistry against GSKβ 24 h later. Scale bar, 50 μm.

Serpina3c Increases Adipogenesis by 3T3-L1 Preadipocytes and Is Increased in Animals and Humans with Obesity {#sec2.5}
------------------------------------------------------------------------------------------------------------

To verify the role of Serpina3c in adipogenesis, the differentiation of adipocytes was examined in cells overexpressing *Serpina3c*. The expression of C/EBPα and PPARγ during differentiation was increased in 3T3-L1 cells transfected with pcDNA3.0 encoding FLAG-tagged Serpina3c ([Figure 6](#fig6){ref-type="fig"}A). Oil Red O staining revealed that the differentiation of these cells was accelerated ([Figure 6](#fig6){ref-type="fig"}B). Consistent with an increase of adipogenesis by Serpina3c, we found that the expression of this factor was higher in epididymal white adipose tissues of mice fed a high-fat diet than in those fed a chow diet ([Figure 6](#fig6){ref-type="fig"}C). When comparing the expression of Serpina3c by the duration of high-fat diet, the Serpina3c expression in high-fat diet for 8 weeks was slightly higher than that of 16 weeks but was not statistically significant. We also accessed a public repository (NCBI, Gene Expression Omnibus GDS5056 and GDS1480) to obtain expression data from adipose stem cells from morbidly obese and non-obese individuals. The expression levels of *SERPINA3,* a human ortholog gene of *SERPINA3C,* was higher in obese individuals than in lean individuals (p \< 0.05; [Figure 6](#fig6){ref-type="fig"}D). These data show that SerpinA3 family proteins, including Serpina3c, play a critical role in adipocyte differentiation and obesity.Figure 6Serpina3c Overexpression Increases Adipocyte Differentiation3T3-L1 cells were transfected with a control (pcDNA 3.0) or Serpina3c overexpression vector and induced to differentiate.(A) Overexpressed Serpina3c was confirmed 2 days after transfection by detection of the FLAG tag from whole-cell lysates. Proteins collected at the indicated times after induction were used to assay the levels of C/EBPα and PPARγ by western blot (GAPDH was used as loading control).(B) Oil Red O staining on day 5.(C) *Serpina3c* expression by quantitative real-time PCR in epididymal WAT tissues from C57BL/6 male mice fed a chow diet (CD) or a high-fat diet (HFD) for 8 or 16 weeks. WAT, white adipose tissue. Data are represented as mean ± SD. p Values less than 0.05 were considered significant, with ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s t test.(D) *SERPINA3* gene expression levels in adipose stem cells or preadipocytes from obese and lean individuals, using publicly available repository data (Gene Expression Omnibus accessions GDS5056 and GDS1480). Data are represented as mean ± SD. p Values less than 0.05 were considered significant, with ∗p \< 0.05, ∗∗p \< 0.01 as determined by Student\'s t test.

Discussion {#sec3}
==========

The mechanisms of 3T3-L1 differentiation have been investigated since these cells were first cloned by Howard Green ([@bib7]). These efforts have identified the roles of transcription factors C/EBPβ, C/EBPα, and PPARγ in adipogenesis ([@bib8], [@bib18]), but the complex molecular processes regulating adipocyte differentiation have yet to be fully defined. In the present study, we found that Serpina3c is a regulator of adipogenesis and was responsible for the accelerated differentiation of adipocytes induced by CM ([@bib2]). We further show that its regulation is via modulation of integrin-IGF-1 signaling.

From the RNA sequencing data, the gene expression profile was compared between CM-induced adipocytes and MDI-induced adipocytes, elucidating *Serpina3c* as a gene expected to be critically involved in adipogenesis. Serpins are the largest and most broadly distributed superfamily of protease inhibitors ([@bib1], [@bib11], [@bib16]), nearly ubiquitous in higher eukaryotes and with highly diverse functions. However, the role of serpins in metabolism has not been investigated fully. SerpinB1 was recently found to promote pancreatic β-cell proliferation and contribute to insulin sensitivity ([@bib4]). With regard to adipocytes, Serpina12 (vaspin \[visceral adipose tissue-derived serine protease inhibitor\]) is the most well-known serpin, functioning as an insulin-sensitizing adipokine in obesity ([@bib10]). Our data here reveal that Serpina3c stimulates adipocyte differentiation.

Serpina3c is a secretory protein that can affect extracellular matrix proteins. We show here that it is a serine protease inhibitor, with one target protein being cathepsin G for integrin α5 degradation ([Figure 4](#fig4){ref-type="fig"}A). The knockdown of *Serpina3c* interfered with IGF-1 signaling, disrupting the activation of ERK and AKT. [Figure 7](#fig7){ref-type="fig"} shows a possible mechanism by which Serpina3c controls adipogenesis. IGF-1 receptors form a complex with integrin α5-β3 heterodimers required for activation of the IGF-1 pathway in 3T3-L1 cells. The binding of IGF-1 to its receptor induces the phosphorylation of integrin β3 to bind Src and activate downstream targets, such as ERK. Serine proteases (e.g., cathepsin G) degrade integrin α5 and abolish Src-mediated ERK activation. In the absence of the integrin complex, IGF-1 signals through insulin response substrate 1, which leads to a sustained AKT signaling and the phosphorylation and nuclear export of GSK3β. Thus, Serpina3c is required for activation of ERK and nuclear translocation of GSK3β, which are both are necessary for C/EBPβ phosphorylation and adipogenesis.Figure 7Schematic Illustration of How Serpina3c Regulates Adipogenesis(A) IGF-1 receptors form a complex with the integrin α5-β3 heterodimer that is required to activate ERK. With ligand binding, integrin β3 is phosphorylated at Tyr759, leading to Src binding and ERK activation. In this situation, Serpina3c blocks any serine proteases, which can degrade integrin α5. Insulin receptor substrate 1 (IRS-1) may transiently induce AKT signaling.(B) In the absence of Serpina3c, serine proteases degrade integrin α5, and the integrin-IGF-1 receptor complex is not formed, resulting in persistent activation of AKT by IRS-1 and phosphorylation of GSK3β, thereby attenuating adipose differentiation.

In summary, the results from this study provide important advances in understanding the mechanism of adipogenesis. We show that CM induces the transcription of several genes, including *Serpina3c*, which stimulates adipocyte differentiation without mitotic clonal expansion. Furthermore, we show that integrin in the extracellular matrix contributes to adipocyte differentiation. Specifically, Serpina3c inhibits serine proteases that degrade integrin α5, thereby shifting IGF-1 signaling away from AKT activation toward ERK signaling via the IGF-1-integrin complex. Thus, Serpina3c plays an important role in the transition from mitotic clonal expansion to terminal differentiation and is critical for adipocyte differentiation and adipogenesis.

Limitations of the Study {#sec3.1}
------------------------

In this study, we suggested cathepsin G as a candidate serine protease that is inhibited by Serpina3c. However, there is a possibility that other proteases under the inhibition of Serpina3c may exist in addition to cathepsin G. Another limitation is that, in humans, Serpina3 clade is consisted of single gene, *SERPINA3*, so it is necessary to confirm whether *SERPINA3* functions in the same mechanism as *SERPINA3C* in mice. In addition, further study using *SERPINA3C* knockout mice should be performed to determine how Serpina3c works *in vivo*. Finally, further purification of Serpina3c protein is needed to fully clarify the effect of Serpina3c overexpression.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The accession numbers for the 3T3-L1 RNA-seq using MDI and CM is GEO: [GSE144130](ncbi-geo:GSE144130){#interref25}. Expression levels of *SERPINA3* in human adipose tissue, which is a human ortholog gene of *SERPINA3C*, were obtained from a public repository (GEO: GDS5056 and GDS 1480). Expression levels of *SERPINA3* were compared among groups by Student's t tests using R version 3.6.0 software (R Development Core Team, Vienna, Austria).
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